Hansoh Pharmaceutical Group Company Limited
3692
Classificação em ações
#908
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Preço da ação
$4.40
Valor de mercado
$26.66B
Variação (1 dia)
8.32%
Variação (1 ano)
-6.19%
País
CN
Negociar Hansoh Pharmaceutical Group Company Limited (3692)
Categoria
Healthcare
Histórico de rendimento de dividendos para Hansoh Pharmaceutical Group Company Limited (3692)
O rendimento de dividendos (TTM) da Hansoh Pharmaceutical Group Company Limited (símbolo da ação: 3692) em 2023-12-31 é: 0.73%
Rendimento médio dos dividendos nos últimos 5 anos: 1.25%
Rendimento médio dos dividendos nos últimos 5 anos: 1.25%
Histórico de rendimento de dividendos para Hansoh Pharmaceutical Group Company Limited (3692) de 2016 a 2026
Rendimento de dividendos no final de cada ano (TTM)
| Ano | Rendimento de Dividendos | Alterar |
|---|---|---|
| 2026 (TTM) | 1.54% | -20.21% |
| 2024 | 1.93% | 164.38% |
| 2023 | 0.73% | -20.65% |
| 2022 | 0.92% | 119.05% |
| 2021 | 0.42% | -81.42% |
| 2020 | 2.26% | 91.53% |
| 2019 | 1.18% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 0.44% | -81.51% |
| 2016 | 2.38% | 0.00% |
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
| Empresa | Rendimento de Dividendos | País |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
